The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
CR

c.ramos

TL2 · Linköping

Contributes reviews on supplier material. Based in Linköping.

Joined 5 March 2025 · last posted 1d

79Posts here
3Topics
0Solutions
1.3kLikes received
852Likes given
19Badges
198Days visited
4kPosts read

Most-liked posts

  • Gastro-oesophageal reflux: improving or worsening? Replied, post #27 · Clinical › Comorbidities · 16 Mar 2026 · 32 likes Nobody has said the unglamorous part of gastro-oesophageal reflux yet, so: most of the variation is explained by things that are boring to write about and easy to check.
  • Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #34 · Research Methods › N-of-1 designs · 7 Jan 2026 · 31 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
  • SURPASS-2 and the comparator dose question that will not go away Replied, post #75 · Compounds › Tirzepatide · 9 Dec 2024 · 31 likes SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens on stopping. It says nothing about a lower maintenance dose, because…
  • Does a peptide degrade silently, with no visual change? Replied, post #80 · Practice › Storage & stability · 27 Jul 2026 · 29 likes Post #78 describes the usual case. This is about the unusual one. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
  • Availability by country, dated, with primary sources Replied, post #38 · Access › International · 29 Oct 2025 · 27 likes Trying to state the availability position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
  • Documentation that appears only after payment Replied, post #7 · Sourcing › Red flags · 18 Aug 2025 · 26 likes Since documentation keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…

Where this member posts

CategoryPostsShare
Compounds1418%
Practice1013%
Analytics911%
Evidence911%
Sourcing810%
Clinical68%

Badges earned, in order

BadgeTierGranted
Basic Userbronze7 Mar 2025
Read the Guidelinesbronze8 Mar 2025
First Replybronze10 Mar 2025
First Topicbronze11 Mar 2025
Asked Wellbronze15 Mar 2025
First Quotebronze19 Mar 2025
First Linkbronze24 Mar 2025
Welcomebronze25 Mar 2025
Sourcedbronze31 Mar 2025
Memberbronze12 Apr 2025
First Tagbronze25 Apr 2025
Generousbronze1 May 2025
First Vendor Reportbronze29 May 2025
Editorbronze31 May 2025
Readerbronze14 Jun 2025
Nice Postbronze19 Aug 2025
Thank Yousilver12 Sep 2025
Good Postsilver5 Dec 2025
Anniversarysilver5 Mar 2026